BDTXBlack Diamond Therapeutics, Inc.
- Market cap
- $108.01M
- as of 2026-10-23
- Latest close
- $1.88
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-19
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Behbahani Ali | Sep 18 | Sep 21 | A | 7,707 | $1.93 | $14,875 | 110,236 | No | Form 4 |
| Raman Prakash | Sep 18 | Sep 21 | A | 6,801 | $1.93 | $13,126 | 51,840 | No | Form 4 |
| Behbahani Ali | Jun 26 | Jun 29 | A · derivative | 40,000 | $1.71 | $68,400 | 40,000 | No | Form 4 |
| Dhingra Kapil | Jun 26 | Jun 29 | A · derivative | 40,000 | $1.71 | $68,400 | 40,000 | No | Form 4 |
| Menzel Garry E | Jun 26 | Jun 29 | A · derivative | 40,000 | $1.71 | $68,400 | 40,000 | No | Form 4 |
| Kulkarni Samarth | Jun 26 | Jun 29 | A · derivative | 40,000 | $1.71 | $68,400 | 40,000 | No | Form 4 |
| Raman Prakash | Jun 26 | Jun 29 | A · derivative | 40,000 | $1.71 | $68,400 | 40,000 | No | Form 4 |
| Campbell Shannon | Jun 26 | Jun 29 | A · derivative | 40,000 | $1.71 | $68,400 | 40,000 | No | Form 4 |
| Behbahani Ali | Jun 19 | Jun 22 | A | 8,961 | $1.66 | $14,875 | 102,529 | No | Form 4 |
| Raman Prakash | Jun 19 | Jun 22 | A | 7,907 | $1.66 | $13,126 | 45,039 | No | Form 4 |
| Behbahani Ali | Mar 20 | Mar 20 | A | 6,919 | $2.15 | $14,876 | 93,568 | No | Form 4 |
| Raman Prakash | Mar 20 | Mar 20 | A | 6,105 | $2.15 | $13,126 | 37,132 | No | Form 4 |
| Hatzis-Schoch BrentSEE REMARKS | Jan 21 | Jan 23 | A · derivative | 250,000 | $2.57 | $642,500 | 250,000 | No | Form 4 |
| Yurasov SergeyCHIEF MEDICAL OFFICER | Jan 21 | Jan 23 | A · derivative | 250,000 | $2.57 | $642,500 | 250,000 | No | Form 4 |
| Velleca Mark A.PRESIDENT & CEO | Jan 21 | Jan 23 | A · derivative | 600,000 | $2.57 | $1,542,000 | 600,000 | No | Form 4 |
| Buck ElizabethCHIEF SCIENTIFIC OFFICER | Jan 21 | Jan 23 | A · derivative | 250,000 | $2.57 | $642,500 | 250,000 | No | Form 4 |
| Jones ErikaSEE REMARKS | Jan 21 | Jan 23 | A · derivative | 200,000 | $2.57 | $514,000 | 200,000 | No | Form 4 |
| Behbahani Ali | Dec 12, 2025 | Dec 15, 2025 | A | 5,208 | $2.76 | $14,374 | 86,649 | No | Form 4 |
| Raman Prakash | Dec 12, 2025 | Dec 15, 2025 | A | 4,665 | $2.76 | $12,875 | 31,027 | No | Form 4 |
| Behbahani Ali | Sep 19, 2025 | Sep 22, 2025 | A | 4,291 | $3.35 | $14,375 | 81,441 | No | Form 4 |
| Raman Prakash | Sep 19, 2025 | Sep 22, 2025 | A | 3,843 | $3.35 | $12,874 | 26,362 | No | Form 4 |
| Behbahani Ali | Jun 20, 2025 | Jun 20, 2025 | A | 6,170 | $2.33 | $14,376 | 77,150 | No | Form 4 |
| Raman Prakash | Jun 20, 2025 | Jun 20, 2025 | A | 5,526 | $2.33 | $12,876 | 22,519 | No | Form 4 |
| Behbahani Ali | Jun 12, 2025 | Jun 12, 2025 | A · derivative | 30,550 | $2.43 | $74,237 | 30,550 | No | Form 4 |
| Kulkarni Samarth | Jun 12, 2025 | Jun 12, 2025 | A · derivative | 30,550 | $2.43 | $74,237 | 30,550 | No | Form 4 |
| Dhingra Kapil | Jun 12, 2025 | Jun 12, 2025 | A · derivative | 30,550 | $2.43 | $74,237 | 30,550 | No | Form 4 |
| Campbell Shannon | Jun 12, 2025 | Jun 12, 2025 | A · derivative | 30,550 | $2.43 | $74,237 | 30,550 | No | Form 4 |
| Raman Prakash | Jun 12, 2025 | Jun 12, 2025 | A · derivative | 30,550 | $2.43 | $74,237 | 30,550 | No | Form 4 |
| Menzel Garry E | Jun 12, 2025 | Jun 12, 2025 | A · derivative | 30,550 | $2.43 | $74,237 | 30,550 | No | Form 4 |
| Behbahani Ali | Mar 21, 2025 | Mar 21, 2025 | A | 7,646 | $1.88 | $14,374 | 70,980 | No | Form 4 |
| Raman Prakash | Mar 21, 2025 | Mar 21, 2025 | A | 6,848 | $1.88 | $12,874 | 16,993 | No | Form 4 |
| Biotech Growth N V | Mar 19, 2025 | Mar 20, 2025 | S | 1,000,000 | $2.07 | Sale −$2,070,000 | 7,517,839 | No | Form 4 |
| Biotech Growth N V | Mar 19, 2025 | Mar 20, 2025 | S | 300,000 | $1.94 | Sale −$582,000 | 7,217,839 | No | Form 4 |
| Biotech Growth N V | Mar 19, 2025 | Mar 20, 2025 | S | 1,000,000 | $2.31 | Sale −$2,310,000 | 6,217,839 | No | Form 4 |
| Biotech Growth N V | Mar 19, 2025 | Mar 20, 2025 | S | 2,000,000 | $2.00 | Sale −$4,000,000 | 4,217,839 | No | Form 4 |
| Biotech Growth N V | Mar 19, 2025 | Mar 20, 2025 | S | 400,000 | $2.09 | Sale −$836,000 | 3,817,839 | No | Form 4 |
| Biotech Growth N V | Mar 19, 2025 | Mar 20, 2025 | S | 584,292 | $1.95 | Sale −$1,139,369 | 3,233,547 | No | Form 4 |
| Biotech Growth N V | Mar 19, 2025 | Mar 20, 2025 | S | 500,000 | $2.12 | Sale −$1,060,000 | 2,733,547 | No | Form 4 |
| Hatzis-Schoch BrentSEE REMARKS | Jan 30, 2025 | Jan 31, 2025 | A | 75,000 | $0.00 | $0 | 83,400 | No | Form 4 |
| Hatzis-Schoch BrentSEE REMARKS | Jan 30, 2025 | Jan 31, 2025 | A · derivative | 175,000 | $2.52 | $441,000 | 175,000 | No | Form 4 |
| Jones ErikaSEE REMARKS | Jan 30, 2025 | Jan 31, 2025 | A | 75,000 | $0.00 | $0 | 85,150 | No | Form 4 |
| Jones ErikaSEE REMARKS | Jan 30, 2025 | Jan 31, 2025 | A · derivative | 125,000 | $2.52 | $315,000 | 125,000 | No | Form 4 |
| Buck ElizabethCHIEF SCIENTIFIC OFFICER | Jan 30, 2025 | Jan 31, 2025 | A | 75,000 | $0.00 | $0 | 170,192 | No | Form 4 |
| Buck ElizabethCHIEF SCIENTIFIC OFFICER | Jan 30, 2025 | Jan 31, 2025 | A · derivative | 175,000 | $2.52 | $441,000 | 175,000 | No | Form 4 |
| Yurasov SergeyCHIEF MEDICAL OFFICER | Jan 30, 2025 | Jan 31, 2025 | A | 75,000 | $0.00 | $0 | 75,000 | No | Form 4 |
| Yurasov SergeyCHIEF MEDICAL OFFICER | Jan 30, 2025 | Jan 31, 2025 | A · derivative | 200,000 | $2.52 | $504,000 | 200,000 | No | Form 4 |
| Velleca Mark A.PRESIDENT & CEO | Jan 30, 2025 | Jan 31, 2025 | A | 75,000 | $0.00 | $0 | 121,522 | No | Form 4 |
| Velleca Mark A.PRESIDENT & CEO | Jan 30, 2025 | Jan 31, 2025 | A · derivative | 500,000 | $2.52 | $1,260,000 | 500,000 | No | Form 4 |
| Behbahani Ali | Dec 13, 2024 | Dec 16, 2024 | A | 5,750 | $2.50 | $14,375 | 63,334 | No | Form 4 |
| Campbell Shannon | Dec 13, 2024 | Dec 16, 2024 | A | 4,500 | $2.50 | $11,250 | 8,865 | No | Form 4 |
| Raman Prakash | Dec 13, 2024 | Dec 16, 2024 | A | 5,150 | $2.50 | $12,875 | 10,145 | No | Form 4 |
| Behbahani Ali | Sep 20, 2024 | Sep 20, 2024 | A | 3,007 | $4.78 | $14,373 | 57,584 | No | Form 4 |
| Raman Prakash | Sep 20, 2024 | Sep 20, 2024 | A | 2,694 | $4.78 | $12,877 | 4,995 | No | Form 4 |
| Campbell Shannon | Sep 20, 2024 | Sep 20, 2024 | A | 2,354 | $4.78 | $11,252 | 4,365 | No | Form 4 |
| Versant Voyageurs I Parallel, L.P. | Aug 28, 2024 | Aug 30, 2024 | S | 221,600 | $6.32 | Sale −$1,400,512 | 3,726,341 | No | Form 4 |
| Behbahani Ali | Jun 21, 2024 | Jun 21, 2024 | A | 2,887 | $4.98 | $14,377 | 54,577 | No | Form 4 |
| Campbell Shannon | Jun 21, 2024 | Jun 21, 2024 | A | 2,011 | $4.98 | $10,015 | 2,011 | No | Form 4 |
| Raman Prakash | Jun 21, 2024 | Jun 21, 2024 | A | 2,301 | $4.98 | $11,459 | 2,301 | No | Form 4 |
| Behbahani Ali | Jun 6, 2024 | Jun 6, 2024 | A · derivative | 30,550 | $4.65 | $142,058 | 30,550 | No | Form 4 |
| Dhingra Kapil | Jun 6, 2024 | Jun 6, 2024 | A · derivative | 30,550 | $4.65 | $142,058 | 30,550 | No | Form 4 |
| Campbell Shannon | Jun 6, 2024 | Jun 6, 2024 | A · derivative | 30,550 | $4.65 | $142,058 | 30,550 | No | Form 4 |
| Raman Prakash | Jun 6, 2024 | Jun 6, 2024 | A · derivative | 30,550 | $4.65 | $142,058 | 30,550 | No | Form 4 |
| Menzel Garry E | Jun 6, 2024 | Jun 6, 2024 | A · derivative | 30,550 | $4.65 | $142,058 | 30,550 | No | Form 4 |
| Kulkarni Samarth | Jun 6, 2024 | Jun 6, 2024 | A · derivative | 30,550 | $4.65 | $142,058 | 30,550 | No | Form 4 |
| Raman Prakash | Apr 10, 2024 | Apr 12, 2024 | A · derivative | 61,100 | $4.98 | $304,278 | 61,100 | No | Form 4 |
| Campbell Shannon | Apr 10, 2024 | Apr 12, 2024 | A · derivative | 61,100 | $4.98 | $304,278 | 61,100 | No | Form 4 |
| Behbahani Ali | Mar 15, 2024 | Apr 3, 2024 | A | 3,166 | $4.54 | $14,374 | 51,690 | No | Form 4 |
| Dixon Wendy L | Mar 15, 2024 | Apr 3, 2024 | A | 3,253 | $4.54 | $14,769 | 38,054 | No | Form 4 |
| Jones ErikaSEE REMARKS | Feb 14, 2024 | Feb 15, 2024 | A · derivative | 100,000 | $4.86 | $486,000 | 100,000 | No | Form 4 |
| Velleca Mark A.PRESIDENT & CEO | Feb 14, 2024 | Feb 15, 2024 | A · derivative | 537,000 | $4.86 | $2,609,820 | 537,000 | No | Form 4 |
| Buck ElizabethCHIEF SCIENTIFIC OFFICER | Feb 14, 2024 | Feb 15, 2024 | A · derivative | 200,000 | $4.86 | $972,000 | 200,000 | No | Form 4 |
| Yurasov SergeyCHIEF MEDICAL OFFICER | Feb 14, 2024 | Feb 15, 2024 | A · derivative | 225,000 | $4.86 | $1,093,500 | 225,000 | No | Form 4 |
| Hatzis-Schoch BrentSEE REMARKS | Feb 14, 2024 | Feb 15, 2024 | A · derivative | 200,000 | $4.86 | $972,000 | 200,000 | No | Form 4 |
| Ni FangSEE REMARKS | Feb 14, 2024 | Feb 15, 2024 | A · derivative | 200,000 | $4.86 | $972,000 | 200,000 | No | Form 4 |
| Behbahani Ali | Dec 15, 2023 | Dec 15, 2023 | A | 4,455 | $2.73 | $12,162 | 48,524 | No | Form 4 |
| Dixon Wendy L | Dec 15, 2023 | Dec 15, 2023 | A | 4,043 | $2.73 | $11,037 | 34,801 | No | Form 4 |
| Biotech Growth N V | Oct 17, 2023 | Oct 19, 2023 | P | 400,000 | $2.34 | Purchase +$936,000 | 8,517,839 | No | Form 4 |